Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

690 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.
Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, Koizumi F, Tamura T, Saito D, Shimoda T, Saka M, Fukagawa T, Katai H, Sano T, Sasako M, Nishio K. Yamada Y, et al. Among authors: hamano t. Cancer Sci. 2008 Nov;99(11):2193-9. doi: 10.1111/j.1349-7006.2008.00935.x. Epub 2008 Jan 11. Cancer Sci. 2008. PMID: 18957060 Free article. Clinical Trial.
Adipocytokines and squamous cell carcinoma of the esophagus.
Nakajima TE, Yamada Y, Hamano T, Furuta K, Oda I, Kato H, Kato K, Hamaguchi T, Shimada Y. Nakajima TE, et al. Among authors: hamano t. J Cancer Res Clin Oncol. 2010 Feb;136(2):261-6. doi: 10.1007/s00432-009-0657-6. Epub 2009 Aug 20. J Cancer Res Clin Oncol. 2010. PMID: 19693538
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.
Ando M, Yamauchi H, Aogi K, Shimizu S, Iwata H, Masuda N, Yamamoto N, Inoue K, Ohono S, Kuroi K, Hamano T, Sukigara T, Fujiwara Y. Ando M, et al. Among authors: hamano t. Breast Cancer Res Treat. 2014 Jun;145(2):401-9. doi: 10.1007/s10549-014-2947-1. Epub 2014 Apr 12. Breast Cancer Res Treat. 2014. PMID: 24728578 Clinical Trial.
An open-label, randomized, phase II trial evaluating the efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer patients previously treated with bevacizumab for front-line or platinum-sensitive ovarian cancer: rationale, design, and methods of the Japanese Gynecologic Oncology Group study JGOG3023.
Shoji T, Komiyama S, Kigawa J, Tanabe H, Kato K, Itamochi H, Fujiwara H, Kamiura S, Hamano T, Sugiyama T; Japanese Gynecologic Oncology Group. Shoji T, et al. Among authors: hamano t. BMC Cancer. 2018 Jul 31;18(1):771. doi: 10.1186/s12885-018-4505-4. BMC Cancer. 2018. PMID: 30064406 Free PMC article. Clinical Trial.
690 results